Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol. 2009;27:621–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke JT, Coyle D, Evans G, Martin J, Winquist E. Toward a functional definition of a “rare disease” for regulatory authorities and funding agencies. Value Health. 2014;17(8):757–61.

Article  PubMed  Google Scholar 

Piskin D, Romano M, Aletaha D, Feldman BM, Goldbach-Mansky R, Carmona L, Demirkaya E. Developing guidelines for ultrarare rheumatic disorders: a bumpy ride. Ann Rheum Dis. 2022. https://doi.org/10.1136/ard-2022-222538

Article  PubMed  Google Scholar 

McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97(1):133–44.

Article  CAS  PubMed  Google Scholar 

Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron KS, et al. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022;81(7):907–21.

Article  CAS  PubMed  Google Scholar 

ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015;74(9):1636–44.

Article  PubMed  Google Scholar 

Broderick L, Hoffman HM. IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. Nat Rev Rheumatol. 2022;18(8):448–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417–26.

Article  CAS  PubMed  Google Scholar 

Challagundla N, Saha B, Agrawal-Rajput R. Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation. Immunol Res. 2022;70(5):578–606. https://doi.org/10.1007/s12026-022-09286-9.

Article  CAS  PubMed  Google Scholar 

Challagundla N, Saha B, Agrawal-Rajput R. Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation. Immunol Res. 2022;70(5):578–606.

Article  CAS  PubMed  Google Scholar 

Harapas CR, Steiner A, Davidson S, Masters SL. An update on autoinflammatory diseases: inflammasomopathies. Curr Rheumatol Rep. 2018;20(7):40.

Article  PubMed  Google Scholar 

Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. https://doi.org/10.3390/ijms20133328.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med. 2011;208(3):519–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savic S, McDermott MF. Tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS). In: Hashkes PJ, Laxer RM, Simon A, editors. Textbook of autoinflammation. Cham: Springer Nature Switzerland AG; 2019. p. 329–45.

Chapter  Google Scholar 

Cudrici C, Deuitch N, Aksentijevich I. Revisiting TNF receptor-associated periodic syndrome (TRAPS): current perspectives. Int J Mol Sci. 2020;21(9):3263. https://doi.org/10.3390/ijms21093263.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M, et al. Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology (Oxford). 2001;40(5):579–84.

Article  CAS  PubMed  Google Scholar 

Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999;22(2):175–7.

Article  CAS  PubMed  Google Scholar 

Politiek FA, Waterham HR. Compromised protein prenylation as pathogenic mechanism in mevalonate kinase deficiency. Front Immunol. 2021;12: 724991.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016;17(8):914–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naik HB, Cowen EW. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013;31(3):405–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360(23):2426–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Welzel T, Benseler SM, Kuemmerle-Deschner JB. Management of monogenic IL-1 mediated autoinflammatory diseases in childhood. Front Immunol. 2021;12: 516427.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnstone RF, Dolen WK, Hoffman HM. A large kindred with familial cold autoinflammatory syndrome. Ann Allergy Asthma Immunol. 2003;90(2):233–7.

Article  PubMed  Google Scholar 

Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108(4):615–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yildiz M, Haslak F, Adrovic A, Barut K, Kasapcopur O. Autoinflammatory diseases in childhood. Balkan Med J. 2020;37(5):236–46.

CAS  PubMed  PubMed Central  Google Scholar 

Nakagawa K, Gonzalez-Roca E, Souto A, Kawai T, Umebayashi H, Campistol JM, et al. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes. Ann Rheum Dis. 2015;74(3):603–10.

Article  CAS  PubMed  Google Scholar 

Kümmerle-Deschner JB, Tyrrell PN, Reess F, Kötter I, Lohse P, Girschick H, et al. Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum. 2010;62(12):3783–91.

Article  PubMed  Google Scholar 

Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50(2):607–12.

Article  CAS  PubMed  Google Scholar 

Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, Kolodner RD, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56(4):1273–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caroli F, Pontillo A, D’Osualdo A, Travan L, Ceccherini I, Crovella S, et al. Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Rheumatology (Oxford). 2007;46(3):473–8.

Article  CAS  PubMed  Google Scholar 

Welzel T, Kuemmerle-Deschner JB. Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today? J Clin Med. 2021;10(1):128. https://doi.org/10.3390/jcm10010128.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldbach-Mansky R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr Rheumatol Rep. 2011;13(2):123–31.

Article  PubMed  PubMed Central  Google Scholar 

Wittkowski H, Kuemmerle-Deschner JB, Austermann J, Holzinger D, Goldbach-Mansky R, Gramlich K, et al. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes. Ann Rheum Dis. 2011;70(12):2075–81.

Article  CAS  PubMed  Google Scholar 

Pastore S, Paloni G, Caorsi R, Ronfani L, Taddio A, Lepore L, et al. Serum amyloid protein A concentration in cryopyrin-associated periodic syndrome patients treated with interleukin-1 beta antagonist. Clin Exp Rheumatol. 2014;32(Supplemen